Michael Scholz

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial

Volker Heinemann, Ludwig Fischer von Weikersthal, Thomas Decker et al. · The Lancet Oncology · 2014 · 1.7K citations

Cetuximab Versus Folfiri, Oncology, Clinical Trials +9

A Genome-wide Search for Linkage to Asthma22See the Appendix.

Matthias Wjst, Guido Fischer, Thomas Immervoll et al. · Genomics · 1999 · 347 citations

Asthma, Genome Study, Genetics +5

The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients

M. K. Steuer-Vogt, V. Bonkowsky, Petra Ambrosch et al. · European Journal of Cancer · 2001 · 169 citations

Neck Cancer Patients, Medicine, Resected Head +5

Neurophysiological assessment of early hepatic encephalopathy

Michael Scholz, H. Hinrichs, Jens Wiltfang et al. · Electroencephalography and Clinical Neurophysiology · 1990 · 138 citations

Early Hepatic Encephalopathy, Neurophysiology, Neuroanatomy +10

Multiple family therapy with eating disordered adolescents: concepts and preliminary results

Michael Scholz, Eia Asen · European Eating Disorders Review · 2001 · 117 citations

Family Medicine, Psychiatry, Eating Disorders +14